Lexicon Pharmaceuticals, Inc. (LXRX)
1.82
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.825
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Gross Profit Margin (Quarterly) : 79.62% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.62% |
| March 31, 2026 | 98.97% |
| December 31, 2025 | 94.19% |
| September 30, 2025 | 98.86% |
| June 30, 2025 | 99.28% |
| March 31, 2025 | 83.68% |
| December 31, 2024 | 98.22% |
| September 30, 2024 | 88.74% |
| June 30, 2024 | 81.48% |
| March 31, 2024 | 84.51% |
| December 31, 2023 | 69.09% |
| September 30, 2023 | 2.47% |
| June 30, 2023 | 52.05% |
| March 31, 2023 | -366.7% |
| December 31, 2022 | -267.9% |
| September 30, 2022 | -176.9% |
| June 30, 2022 | -205.7% |
| March 31, 2022 | -194.6% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 83.16% |
| June 30, 2020 | 87.69% |
| Date | Value |
|---|---|
| March 31, 2020 | 86.57% |
| December 31, 2019 | 86.15% |
| September 30, 2019 | 99.63% |
| June 30, 2019 | 81.03% |
| March 31, 2019 | 88.56% |
| December 31, 2018 | 94.25% |
| September 30, 2018 | 84.65% |
| June 30, 2018 | 90.10% |
| March 31, 2018 | 95.83% |
| December 31, 2017 | 97.09% |
| September 30, 2017 | 95.84% |
| June 30, 2017 | 91.25% |
| March 31, 2017 | 95.85% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 67.95% |
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.60% |
| Return on Assets | -26.91% |
| Return on Invested Capital | -29.38% |
| Profit Margin (Quarterly) | -4.59K% |
| Operating Margin (Quarterly) | -3.84K% |
| Return on Net Operating Assets | -106.2% |